Valuation: Thyrocare Technologies Limited

Capitalization 7.5TCr 77Cr 67Cr 61Cr 58Cr 106.55Cr 109.23Cr 728.92Cr 283.86Cr 3.53TCr 290.51Cr 284.32Cr 12TCr P/E ratio 2026
34.2x
P/E ratio 2027 * 38.7x
Enterprise value 7.5TCr 77Cr 67Cr 61Cr 58Cr 106.55Cr 109.23Cr 728.92Cr 283.86Cr 3.53TCr 290.51Cr 284.32Cr 12TCr EV / Sales 2026
6.71x
EV / Sales 2027 * 7.61x
Free-Float
38.92%
Yield 2026 *
2%
Yield 2027 * 2.44%
1 day+1.34%
1 week-0.08%
Current month+19.15%
1 month+21.47%
3 months+19.40%
6 months-6.19%
Current year+7.01%
1 week 445
Extreme 445
487.7
1 month 385.05
Extreme 385.05
526
Current year 342.55
Extreme 342.55
526
1 year 291.37
Extreme 291.3667
536.67
3 years 149.33
Extreme 149.3333
536.67
5 years 138.47
Extreme 138.4667
536.67
10 years 135.72
Extreme 135.7167
536.67
Manager TitleAgeSince
Chief Executive Officer - 04/05/2022
Director of Finance/CFO - 24/07/2025
Chief Operating Officer - 18/12/2025
Director TitleAgeSince
Director/Board Member 54 -
Director/Board Member - 12/08/2017
Chairman - -
Change 5d. change 1-year change 3-years change Capi.($)
+1.33%-0.08% - - 77Cr
+1.82%-4.00%+27.91%+286.44% 2.81TCr
+0.05%-2.43%-31.01%-49.13% 645.35Cr
-1.51%-4.73%-12.05%+86.87% 419.51Cr
-2.27%+5.71%+18.07%+65.06% 294.21Cr
+1.99%-3.50%-13.53%-64.73% 178.19Cr
-1.92%-5.72%+19.04%-4.19% 164.68Cr
+1.66%-6.23%+29.31%-30.36% 170.2Cr
-2.41%-1.80%+37.44%+239.22% 138.18Cr
-1.31%+6.69%-40.68%+549.15% 125.08Cr
Average -0.25%-1.19%+3.83%+119.81% 549.22Cr
Weighted average by Cap. +0.75%-2.87%+13.03%+184.59%

Financials

2026 2027 *
Net sales 822.95Cr 8.5Cr 7.33Cr 6.72Cr 6.35Cr 12Cr 12Cr 80Cr 31Cr 387.41Cr 32Cr 31Cr 1.35TCr 984.33Cr 10Cr 8.77Cr 8.03Cr 7.59Cr 14Cr 14Cr 96Cr 37Cr 463.38Cr 38Cr 37Cr 1.62TCr
Net income 157.15Cr 1.62Cr 1.4Cr 1.28Cr 1.21Cr 2.23Cr 2.29Cr 15Cr 5.95Cr 74Cr 6.09Cr 5.96Cr 258.33Cr 193.83Cr 2Cr 1.73Cr 1.58Cr 1.49Cr 2.76Cr 2.82Cr 19Cr 7.34Cr 91Cr 7.51Cr 7.35Cr 318.63Cr
Net Debt - -
Logo Thyrocare Technologies Limited
Thyrocare Technologies Limited is an India-based company, which operates as a healthcare services provider. It offers a range of diagnostic and related healthcare tests and services that are focused on early detection, preventive care, and ongoing disease monitoring. Its segments include diagnostic testing services, Imaging Services, and others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. The Imaging Services include diagnostic and imaging services, the selling of radiopharmaceuticals, and consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and the selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, and a medical cyclotron facility across India. It is also focused on offering pathological services.
Employees
1,822
Date Price Change Volume
20/26/20 476.90 +1.33% 1,25,184
19/26/19 470.65 +4.08% 6,17,025
18/26/18 452.20 -2.15% 3,28,069
15/26/15 462.15 -1.92% 2,32,499
14/26/14 471.20 -1.29% 3,29,005
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
470.90INR
Average target price
600.00INR
Spread / Average Target
+27.42%

Quarterly revenue - Rate of surprise